| 000 | 03072nam a22005055i 4500 | ||
|---|---|---|---|
| 001 | 978-0-387-24199-9 | ||
| 003 | DE-He213 | ||
| 005 | 20250710083931.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2005 xxu| s |||| 0|eng d | ||
| 020 |
_a9780387241999 _a99780387241999 |
||
| 024 | 7 |
_a10.1007/b104814 _2doi |
|
| 082 | 0 | 4 |
_a616.994 _223 |
| 100 | 1 |
_aAbrey, Lauren E. _eeditor. |
|
| 245 | 1 | 0 |
_aLeptomeningeal Metastases _h[recurso electrónico] / _cedited by Lauren E. Abrey, Marc C. Chamberlain, Herbert H. Engelhard. |
| 264 | 1 |
_aBoston, MA : _bSpringer US, _c2005. |
|
| 300 |
_aVII, 196 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_arecurso en línea _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aCancer Treatment and Research, _x0927-3042 ; _v125 |
|
| 505 | 0 | _aAnatomy and Physiology of the Leptomeninges and CSF Space -- Leptomeningeal Neoplasia: Epidemiology, Clinical Presentation, CSF Analysis and Diagnostic Imaging -- Leptomeningeal Metastases from Solid Tumors (Meningeal Carcinomatosis) -- Leptomeningeal Metastases from Leukemias and Lymphomas -- Leptomeningeal Metastasis of Primary Central Nervous System (CNS) Neoplasms -- Leptomeningeal Cancer in the Pediatric Patient -- Neurosurgical Interventions for Leptomeningeal Tumor -- Current Treatment of Leptomeningeal Metastases: Systemic Chemotherapy, Intrathecal Chemotherapy and Symptom Management -- Radiation Therapy for Leptomeningeal Cancer -- Animal Models of Leptomeningeal Cancer -- Improving the Outcome of Patients with Leptomeningeal Cancer: New Clinical Trials and Experimental Therapies. | |
| 520 | _aLeptomeningeal Metastases provides the reader with an overview of the state-of-the-art therapy for the leptomeningeal patient with additional information on epidemiology, symptom management, new clinical trials, and current basic research in animal models for experimental therapies. "Leptomeningeal metastases remains a devastating manifestation of hematologic malignancies and solid tumors. Leading figures in the field review the pathophysiology and clinical consequences of this process. State-of-the-art treatment strategies are presented highlighting advances in current management." Steven T. Rosen, M.D. Series Editor | ||
| 650 | 0 | _aMEDICINE. | |
| 650 | 0 | _aNEUROLOGY. | |
| 650 | 0 | _aNEUROSURGERY. | |
| 650 | 0 | _aONCOLOGY. | |
| 650 | 0 |
_aCANCER _xSURGERY. |
|
| 650 | 1 | 4 | _aMEDICINE & PUBLIC HEALTH. |
| 650 | 2 | 4 | _aONCOLOGY. |
| 650 | 2 | 4 | _aNEUROLOGY. |
| 650 | 2 | 4 | _aNEUROSURGERY. |
| 650 | 2 | 4 | _aSURGICAL ONCOLOGY. |
| 700 | 1 |
_aChamberlain, Marc C. _eeditor. |
|
| 700 | 1 |
_aEngelhard, Herbert H. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9780387241982 |
| 830 | 0 |
_aCancer Treatment and Research, _x0927-3042 ; _v125 |
|
| 856 | 4 | 0 |
_uhttp://dx.doi.org/10.1007/b104814 _zVer el texto completo en las instalaciones del CICY |
| 912 | _aZDB-2-SME | ||
| 942 |
_2ddc _cER |
||
| 999 |
_c56315 _d56315 |
||